HER2DX
LIVE

Serial Number

79312395

Owner

REVEAL GENOMICS S.L.

Attorney

Donna A. Tobin

Filing Date

Mar 19, 2021

Add to watchlist:

No watchlists yet
View on USPTO

HER2DX Trademark

Serial Number: 79312395 • Registration: 6908909

HER2DX is a trademark filed by REVEAL GENOMICS S.L. on March 19, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

REVEAL GENOMICS S.L. (4 trademarks)

Villarroel 170, 2, Planta 5

Entity Type: 16

Trademark Details

Filing Date

March 19, 2021

Registration Date

November 29, 2022

Published for Opposition

September 13, 2022

Goods & Services

Products for medical diagnostics, namely, medical diagnostic reagents, medical diagnostic assays for testing body fluids and tissue, and specimen collection kits comprised of swabs for medical purposes and plastic bags for transmitting medical specimens, all for use in cancer detection; diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; medical reagents for clinical use; medical diagnostic reagents for the analysis of body fluids and tissue; diagnostic reagents for use in diagnostic testing for medical purposes; diagnostic biomarker reagents for cancer diagnosis, prognosis and treatment for medical purposes; medical diagnostic kits comprised of medical diagnostic reagents and assays for testing of body fluids and tissue, and diagnostic reagents for medical use, all for cancer diagnosis, prognosis and treatment; pharmaceutical products for the treatment of cancer; biological preparations for cancer treatment; biopharmaceutical preparations for cancer treatment; pharmaceutical preparations for the treatment of cancer for oncological use; biological reagents, namely, clinical medical reagents; diagnostic reagent kits consisting primarily of diagnostic reagents for medical use, in the field of cancer

Diagnostic preparations for scientific use; reagents for research purposes; reagents for medical research purposes; diagnostic reagents for scientific use or for research use; reagents for scientific use or for research use in the field of cancer; diagnostic reagents for clinical or medical laboratory use in the field of in vitro in biochemistry, clinical chemistry and microbiology

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 12, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 17, 2023 FICS
FINAL DISPOSITION PROCESSED
Mar 17, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 28, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 29, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 29, 2022 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 27, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 9, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 9, 2022 OPNR
NOTIFICATION PROCESSED BY IB
Oct 3, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 13, 2022 NPUB
PUBLISHED FOR OPPOSITION
Sep 13, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 7, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 7, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 24, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 4, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 15, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 15, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 15, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 15, 2022 CNEA
EXAMINER'S AMENDMENT ENTERED
Jun 14, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 14, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 14, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 14, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 3, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 3, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 3, 2022 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 26, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 26, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 26, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 26, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 26, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 26, 2022 COAR
REFUSAL PROCESSED BY IB
Dec 26, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 3, 2021 RFCS
REFUSAL PROCESSED BY MPU
Dec 3, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 3, 2021 RFCR
NON-FINAL ACTION WRITTEN
Nov 2, 2021 CNRT
ASSIGNED TO EXAMINER
Oct 24, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 11, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 7, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 3, 2021 REPR